Volver a Agenda
Session 8: Assessing Individual Case Safety Reports
Session Chair(s)
Mark Vieder, MBA, RPH
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
This session will provide details on seriousness, expectedness, and causality assessment of serious adverse events in clinical trials.
¿Tiene una cuenta?